128 related articles for article (PubMed ID: 20394493)
1. Treatment with topical tacrolimus favors chronic actinic dermatitis: a clinical and immunopathological study.
Ma Y; Lu Z
J Dermatolog Treat; 2010 May; 21(3):171-7. PubMed ID: 20394493
[TBL] [Abstract][Full Text] [Related]
2. The comparative effects of tacrolimus and hydrocortisone in adult atopic dermatitis: an immunohistochemical study.
Caproni M; Torchia D; Antiga E; Terranova M; Volpi W; del Bianco E; D'Agata A; Fabbri P
Br J Dermatol; 2007 Feb; 156(2):312-9. PubMed ID: 17223872
[TBL] [Abstract][Full Text] [Related]
3. A case of chronic actinic dermatitis treated with topical tacrolimus.
Baldo A; Prizio E; Mansueto G; Somma P; Monfrecola G
J Dermatolog Treat; 2005; 16(4):245-8. PubMed ID: 16249148
[TBL] [Abstract][Full Text] [Related]
4. Three times weekly tacrolimus ointment reduces relapse in stabilized atopic dermatitis: a new paradigm for use.
Paller AS; Eichenfield LF; Kirsner RS; Shull T; Jaracz E; Simpson EL;
Pediatrics; 2008 Dec; 122(6):e1210-8. PubMed ID: 19015204
[TBL] [Abstract][Full Text] [Related]
5. Skin and systemic pharmacokinetics of tacrolimus following topical application of tacrolimus ointment in adults with moderate to severe atopic dermatitis.
Undre NA; Moloney FJ; Ahmadi S; Stevenson P; Murphy GM
Br J Dermatol; 2009 Mar; 160(3):665-9. PubMed ID: 19076975
[TBL] [Abstract][Full Text] [Related]
6. Comparing tacrolimus ointment and oral cyclosporine in adult patients affected by atopic dermatitis: a randomized study.
Pacor ML; Di Lorenzo G; Martinelli N; Mansueto P; Rini GB; Corrocher R
Clin Exp Allergy; 2004 Apr; 34(4):639-45. PubMed ID: 15080819
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of tacrolimus ointment in pediatric Patients with moderate to severe atopic dermatitis.
Singalavanija S; Noppakun N; Limpongsanuruk W; Wisuthsarewong W; Aunhachoke K; Chunharas A; Wananukul S; Akaraphanth R
J Med Assoc Thai; 2006 Nov; 89(11):1915-22. PubMed ID: 17205874
[TBL] [Abstract][Full Text] [Related]
8. Two topical calcineurin inhibitors for the treatment of atopic dermatitis in pediatric patients: a meta-analysis of randomized clinical trials.
Chen SL; Yan J; Wang FS
J Dermatolog Treat; 2010 May; 21(3):144-56. PubMed ID: 20394490
[TBL] [Abstract][Full Text] [Related]
9. Tacrolimus ointment is safe and effective in the treatment of atopic dermatitis: results in 8000 patients.
Koo JY; Fleischer AB; Abramovits W; Pariser DM; McCall CO; Horn TD; Gottlieb AB; Jaracz E; Rico MJ
J Am Acad Dermatol; 2005 Aug; 53(2 Suppl 2):S195-205. PubMed ID: 16021175
[TBL] [Abstract][Full Text] [Related]
10. Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children.
Remitz A; Harper J; Rustin M; Goldschmidt WF; Palatsi R; van der Valk PG; Sharpe G; Smith CH; Dobozy A; Turjanmaa K;
Acta Derm Venereol; 2007; 87(1):54-61. PubMed ID: 17225017
[TBL] [Abstract][Full Text] [Related]
11. Topical tacrolimus (FK506) leads to profound phenotypic and functional alterations of epidermal antigen-presenting dendritic cells in atopic dermatitis.
Wollenberg A; Sharma S; von Bubnoff D; Geiger E; Haberstok J; Bieber T
J Allergy Clin Immunol; 2001 Mar; 107(3):519-25. PubMed ID: 11240954
[TBL] [Abstract][Full Text] [Related]
12. A multicentre, randomized, double-blind, controlled study of long-term treatment with 0.1% tacrolimus ointment in adults with moderate to severe atopic dermatitis.
Reitamo S; Ortonne JP; Sand C; Cambazard F; Bieber T; Fölster-Holst R; Vena G; Bos JD; Fabbri P; Groenhoej Larsen C;
Br J Dermatol; 2005 Jun; 152(6):1282-9. PubMed ID: 15948994
[TBL] [Abstract][Full Text] [Related]
13. A 4-year follow-up study of atopic dermatitis therapy with 0.1% tacrolimus ointment in children and adult patients.
Reitamo S; Rustin M; Harper J; Kalimo K; Rubins A; Cambazard F; Brenninkmeijer EE; Smith C; Berth-Jones J; Ruzicka T; Sharpe G; Taieb A;
Br J Dermatol; 2008 Sep; 159(4):942-51. PubMed ID: 18637898
[TBL] [Abstract][Full Text] [Related]
14. Non-melanoma skin cancer in patients with atopic dermatitis treated with topical tacrolimus.
Naylor M; Elmets C; Jaracz E; Rico JM
J Dermatolog Treat; 2005 Aug; 16(3):149-53. PubMed ID: 16096180
[TBL] [Abstract][Full Text] [Related]
15. Long-term treatment with 0.1% tacrolimus ointment in adults with atopic dermatitis: results of a two-year, multicentre, non-comparative study.
Reitamo S; Ortonne JP; Sand C; Bos J; Cambazard F; Bieber T; Grønhøj-Larsen C; Rustin M; Fölster-Holst R; Schuttelaar M;
Acta Derm Venereol; 2007; 87(5):406-12. PubMed ID: 17721647
[TBL] [Abstract][Full Text] [Related]
16. Tacrolimus decreases the expression of eotaxin, CCR3, RANTES and interleukin-5 in atopic dermatitis.
Park CW; Lee BH; Han HJ; Lee CH; Ahn HK
Br J Dermatol; 2005 Jun; 152(6):1173-81. PubMed ID: 15948978
[TBL] [Abstract][Full Text] [Related]
17. Successful treatment of nodular actinic reticuloid with tacrolimus ointment.
Gröne D; Kunz M; Zimmermann R; Gross G
Dermatology; 2006; 212(4):377-80. PubMed ID: 16707890
[TBL] [Abstract][Full Text] [Related]
18. Reduced dermal infiltration of cytokine-expressing inflammatory cells in atopic dermatitis after short-term topical tacrolimus treatment.
Simon D; Vassina E; Yousefi S; Kozlowski E; Braathen LR; Simon HU
J Allergy Clin Immunol; 2004 Oct; 114(4):887-95. PubMed ID: 15480330
[TBL] [Abstract][Full Text] [Related]
19. [FK 506 ointment 0.1 % - A new therapeutic option for atopic blepharitis. Clinical trial with 14 patients].
Mayer K; Reinhard T; Reis A; Böhringer D; Sundmacher R
Klin Monbl Augenheilkd; 2001 Nov; 218(11):733-6. PubMed ID: 11731901
[TBL] [Abstract][Full Text] [Related]
20. Tacrolimus ointment 0.1% in the treatment of allergic contact eyelid dermatitis.
Katsarou A; Armenaka M; Vosynioti V; Lagogianni E; Kalogeromitros D; Katsambas A
J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):382-7. PubMed ID: 19207676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
